Clinical Trial Update: Study of Rituximab to Treat Chronic Renal Transplant Rejection [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating rituximab for chronic renal transplant rejection has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Rejection
• Kidney Transplantation

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: King's College London | Conditions: Kidney Transplantation, Graft Rejection | Phase 4 | Status: COMPLETED